Applied Therapeutics receives 180-day extension to meet Nasdaq bid price minimum; transfer to Capital Market

Applied Therapeutics, Inc.

Nasdaq granted until Feb 2, 2026 to regain compliance with $1.00 minimum bid price requirement.
Listing will transfer from Nasdaq Global Market to Nasdaq Capital Market effective Aug 15, 2025.
Company will consider reverse stock split among options to regain compliance.
If bid price closes at $1.00+ for 10 consecutive business days before Feb 2, compliance confirmed.
Failure to regain compliance could lead to delisting; company may appeal to Nasdaq panel.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.